Watch CBS News

New England Biolabs, Rubicon Genomics In Distribution Agreement

ANN ARBOR -- New England Biolabs Inc. and Ann Arbor-based Rubicon Genomics said Tuesday that they have signed a distribution agreement whereby NEB will distribute a product that uses Rubicon's proprietary amplification technology to enable the amplification of DNA from single cells or extremely low amounts of input DNA.

The Single Cell Whole Genome Amplification Kit is the first product available from NEB targeted at the single cell amplification market, and is expected to find use in numerous research applications, including cancer studies.

"New England Biolabs is excited to expand our product portfolio with reagents for single cell amplification, an emerging new area of genomic research," said Salvatore Russello, associate director of business development at NEB. "We look forward to facilitating the adoption of this unique technology in basic and applied research worldwide."

"NEB is an outstanding partner and we look forward to working with them to leverage our early successes in the diagnostic market into the research market, an important area of growth for our company," said Jim Koziarz, president and CEO of Rubicon. "This single cell amplification technology has already been widely adopted in the in vitro fertilization market, and we are excited at the prospects this product has in research applications."

The Single Cell WGA Kit was released through NEB's global sales and distribution network on Oct. 7.

More at www.neb.com and www.rubicongenomics.com.

View CBS News In
CBS News App Open
Chrome Safari Continue
Be the first to know
Get browser notifications for breaking news, live events, and exclusive reporting.